Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immune checkpoint inhibitors
Page 1 of 2 ( 51 items )
<<
1
2
>>
1
When new therapies arrive, we should think more: The unseen challenges of immunotherapy-induced remodeling
11/21/2025 3:54:19 AM |
Browse: 19 |
Download: 48
2
Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review
7/9/2025 7:00:43 AM |
Browse: 54 |
Download: 222
3
Early identification and multidisciplinary management of immune checkpoint inhibitors associated colitis can improve patient outcomes
12/27/2024 1:37:13 PM |
Browse: 106 |
Download: 471
4
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM |
Browse: 148 |
Download: 681
5
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
9/19/2024 12:00:22 PM |
Browse: 125 |
Download: 521
6
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
9/18/2024 11:53:42 AM |
Browse: 118 |
Download: 451
7
Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
2/15/2023 12:44:08 AM |
Browse: 364 |
Download: 1394
8
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
10/18/2022 8:29:59 AM |
Browse: 444 |
Download: 1365
9
Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report
9/29/2022 9:17:29 AM |
Browse: 459 |
Download: 1491
10
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 587 |
Download: 1537
11
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
7/27/2022 1:17:37 PM |
Browse: 735 |
Download: 1523
12
Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
7/22/2022 9:38:18 AM |
Browse: 550 |
Download: 1431
13
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM |
Browse: 611 |
Download: 1429
14
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM |
Browse: 625 |
Download: 1381
15
Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
5/25/2022 8:33:35 AM |
Browse: 511 |
Download: 1221
16
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
5/24/2022 12:41:49 PM |
Browse: 526 |
Download: 1069
17
Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
5/24/2022 12:41:49 PM |
Browse: 502 |
Download: 1489
18
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM |
Browse: 539 |
Download: 1336
19
Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
4/21/2022 11:35:30 AM |
Browse: 398 |
Download: 1037
20
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
2/23/2022 3:51:55 PM |
Browse: 555 |
Download: 1768
21
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
2/11/2022 5:55:20 AM |
Browse: 519 |
Download: 1574
22
Update on the treatment of metastatic renal cell carcinoma
1/22/2022 6:17:12 AM |
Browse: 563 |
Download: 1124
23
Targets of immunotherapy for hepatocellular carcinoma: An update
1/21/2022 8:16:14 AM |
Browse: 534 |
Download: 1129
24
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
1/11/2022 12:11:23 AM |
Browse: 562 |
Download: 1547
25
New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies
12/24/2021 9:48:20 AM |
Browse: 534 |
Download: 1215
26
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
12/17/2021 8:56:01 AM |
Browse: 638 |
Download: 1441
27
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
11/6/2021 4:43:07 AM |
Browse: 682 |
Download: 1602
28
Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
10/21/2021 8:44:04 AM |
Browse: 580 |
Download: 1288
29
Immune checkpoint inhibitor-related hepatotoxicity: A review
8/25/2021 2:11:51 AM |
Browse: 740 |
Download: 1552
30
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
8/14/2021 11:08:13 AM |
Browse: 721 |
Download: 1242
31
Current cancer therapies and their influence on glucose control
7/12/2021 5:45:28 AM |
Browse: 653 |
Download: 1506
32
Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature
5/26/2021 9:58:02 AM |
Browse: 621 |
Download: 1606
33
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
5/14/2021 9:21:56 AM |
Browse: 628 |
Download: 1837
34
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
1/7/2021 10:14:28 AM |
Browse: 644 |
Download: 1266
35
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
12/18/2020 12:27:09 PM |
Browse: 719 |
Download: 1592
36
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
11/26/2020 8:54:27 AM |
Browse: 823 |
Download: 1633
37
Deep diving in the PACIFIC: Practical issues in stage III non-small-cell lung cancer to avoid shipwreck
11/18/2020 2:20:37 PM |
Browse: 973 |
Download: 1661
38
Steroid-responsive pancreatitides
8/25/2020 9:45:46 AM |
Browse: 826 |
Download: 1940
39
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM |
Browse: 1088 |
Download: 2287
40
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM |
Browse: 1155 |
Download: 1951
41
Antibiotics and immunotherapy in gastrointestinal tumors: friend or foe?
6/6/2019 5:44:00 PM |
Browse: 1099 |
Download: 2057
42
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
5/28/2019 9:29:42 AM |
Browse: 1088 |
Download: 2159
43
Immune checkpoint inhibitor-induced colitis: A comprehensive review
2/26/2019 9:05:11 AM |
Browse: 960 |
Download: 1785
44
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
9/20/2018 2:33:54 AM |
Browse: 1077 |
Download: 1929
45
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
8/27/2018 7:22:43 AM |
Browse: 1242 |
Download: 1770
46
Immunotherapies in sarcoma: Updates and future perspectives
4/7/2017 8:24:12 AM |
Browse: 1188 |
Download: 1727
47
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
2/27/2017 6:19:00 PM |
Browse: 1168 |
Download: 1733
48
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM |
Browse: 1192 |
Download: 1833
49
Immune checkpoint therapy for pancreatic cancer
11/18/2016 3:13:00 PM |
Browse: 1243 |
Download: 1708
50
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?
8/10/2016 3:41:00 PM |
Browse: 1419 |
Download: 2065
Page 1 of 2 ( 51 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345